NasdaqGM - Nasdaq Real Time Price USD
Evolus, Inc. (EOLS)
9.19
-0.15
(-1.61%)
At close: May 30 at 4:00:00 PM EDT
9.28
+0.09
+(0.98%)
After hours: May 30 at 6:49:07 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 4 | 4 |
| Avg. Estimate | -0.09 | -0.06 | -0.13 | 0.58 |
| Low Estimate | -0.11 | -0.11 | -0.22 | 0.39 |
| High Estimate | -0.05 | 0.01 | -0.01 | 0.94 |
| Year Ago EPS | -0.06 | -0.18 | -0.34 | -0.13 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 7 | 6 | 7 | 7 |
| Avg. Estimate | 82.18M | 85.31M | 348.21M | 463.84M |
| Low Estimate | 80M | 82.32M | 345.1M | 444.3M |
| High Estimate | 86.38M | 91.18M | 353.73M | 485M |
| Year Ago Sales | 66.91M | 61.09M | 266.27M | 348.21M |
| Sales Growth (year/est) | 22.83% | 39.66% | 30.77% | 33.21% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.06 | -0.11 | 0.02 | -0.14 |
| EPS Actual | -0.06 | -0.18 | 0.01 | -0.17 |
| Difference | -0 | -0.07 | -0.01 | -0.03 |
| Surprise % | -6.35% | -66.67% | -37.75% | -18.61% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.09 | -0.06 | -0.13 | 0.58 |
| 7 Days Ago | -0.09 | -0.06 | -0.13 | 0.58 |
| 30 Days Ago | -0.09 | -0.06 | -0.12 | 0.62 |
| 60 Days Ago | -0.08 | -0.05 | -0.06 | 0.7 |
| 90 Days Ago | 0 | -0.02 | 0 | 0.73 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | 1 | 1 |
| Down Last 30 Days | -- | -- | 1 | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| EOLS | -42.63% | 68.95% | 61.71% | 550.00% |
| S&P 500 | 13.08% | 2.49% | 7.56% | 13.96% |
Upgrades & Downgrades
| Reiterates | Needham: Buy to Buy | 5/8/2025 |
| Initiated | BTIG: Buy | 4/17/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 4/10/2025 |
| Reiterates | Needham: Buy to Buy | 4/9/2025 |
| Maintains | Barclays: Overweight to Overweight | 3/5/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/5/2025 |
Related Tickers
HROW Harrow, Inc.
28.11
+3.35%
ANIK Anika Therapeutics, Inc.
11.15
-0.98%
ETON Eton Pharmaceuticals, Inc.
18.89
-0.16%
DERM Journey Medical Corporation
8.06
-0.12%
069620.KS Daewoong Pharmaceutical Co., Ltd
166,900.00
+5.17%
GALDz.XC
DVAX Dynavax Technologies Corporation
9.79
+0.31%
TXMD TherapeuticsMD, Inc.
1.4600
-1.35%
LNTH Lantheus Holdings, Inc.
75.56
+0.05%
LFCR Lifecore Biomedical, Inc.
6.77
-1.17%